Like Reply 2 Reactions 3 Reactions Gala Health 1y Report this comment More to come
Genetic evidence, such as GWAS, has identified the single-nucleotide polymorphism (SNP) in GIPR, showing that lower function of GIPR is associated with lower BMI (6466), allowing speculation that higher GIPR activity is obesity promoting
They are not intended to represent clinical evidence in humans, and GHK-Cu has not been approved by the FDA, EMA, or any other regulatory authority for any indication
,
Soresi, M
Wegovy, a medication that contains semaglutide, the same main ingredient as Ozempic, and Zepbound, a medication that contains tirzepatide, the same main ingredient as Mounjaro, are both FDA-approved for weight loss